Paper published in a journal (Scientific congresses and symposiums)
Ribociclib + Fulvestrant in hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer : MONALEESA-3 biomarker analyses
Neven, P.; Petrakova, K.; Bianchi, G.V. et al.
2018In Annals of Oncology, 29 (supplement 8), p. 113 - viii 114
Peer Reviewed verified by ORBi
 

Files


Full Text
Ribociclib + Fulvestrant in hormone receptor-positive, human epidermal growth factor ... abstract GJ.pdf
Publisher postprint (94.79 kB)
Request a copy
Annexes
Ribociclib + Fulvestrant in hormone receptor-positive, human epidermal growth factor ... poster GJ.pdf
Publisher postprint (274.76 kB)
Request a copy

All documents in ORBi are protected by a user license.

Send to



Details



Keywords :
oncology
Disciplines :
Oncology
Author, co-author :
Neven, P.
Petrakova, K.
Bianchi, G.V.
De La Cruz Merino, L.
JERUSALEM, Guy  ;  Centre Hospitalier Universitaire de Liège - CHU > Département de médecine interne > Service d'oncologie médicale
Beck, J.T.
Sonke, G.S.
Chia, S.
Brucker, S.
Wang, Y.
He, W.
Rodriguez Lorenc, K.
Su, F.
Im, S-A.
More authors (4 more) Less
Language :
English
Title :
Ribociclib + Fulvestrant in hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer : MONALEESA-3 biomarker analyses
Publication date :
October 2018
Event name :
ESMO 2018 Congress
Event place :
Munich, Germany
Event date :
19-23 October 2018
Audience :
International
Journal title :
Annals of Oncology
ISSN :
0923-7534
eISSN :
1569-8041
Publisher :
Oxford University Press, United Kingdom
Volume :
29
Issue :
supplement 8
Pages :
viii 113 - viii 114
Peer reviewed :
Peer Reviewed verified by ORBi
Available on ORBi :
since 01 March 2020

Statistics


Number of views
42 (1 by ULiège)
Number of downloads
1 (1 by ULiège)

Bibliography


Similar publications



Contact ORBi